The following table shows the list of Horizon 2020 projects developed by "FORUM EUROPEEN DES PATIENTS (FPE)". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 78˙000.00 | 2015-07-01 | 714 |
2 | PREFER | H2020-EU.3.1.7. | participant | 65˙000.00 | 2016-10-01 | 670 |
3 | COMPAR-EU | H2020-EU.3.1.3. | participant | 477˙458.00 | 2018-01-01 | 536 |
4 | PARADIGM | H2020-EU.3.1.7. | coordinator | 702˙516.00 | 2018-03-01 | 604 |
5 | EFOEUPATI | H2020-EU.3.1.7. | coordinator | 188˙340.00 | 2018-09-01 | 314 |
6 | DigitalHealthEurope | H2020-EU.3.1.5.2.;H2020-EU.3.1.4.1.;H2020-EU.3.1.5.1.;H2020-EU.3.1.4.2. | participant | 120˙806.00 | 2019-01-01 | 298 |
7 | EHDEN | H2020-EU.3.1.7. | participant | 236˙250.00 | 2018-11-01 | 358 |
8 | IMMUcan | H2020-EU.3.1.7. | participant | 250˙000.00 | 2019-03-01 | 353 |
9 | EU-PEARL | H2020-EU.3.1.7. | participant | 459˙250.00 | 2019-11-01 | 336 |
10 | PERMIT | H2020-EU.3.1.6. | participant | 57˙500.00 | 2020-01-01 | 287 |
11 | ImmUniverse | H2020-EU.3.1.7. | participant | 11˙781.00 | 2020-01-01 | 346 |
12 | PharmaLedger | H2020-EU.3.1.7. | participant | 143˙750.00 | 2020-01-01 | 409 |
13 | EATRIS-Plus | H2020-EU.1.4.1.1. | participant | 235˙383.00 | 2020-01-01 | 312 |
totale | 3˙026˙034.00 |
This organization collaborated with partners in 26 countries.
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PREFER this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
participant | BE | MB | MINDBYTES (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project COMPAR-EU this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | iMTA | INSTITUTE FOR MEDICAL TECHNOLOGY ASSESSMENT BV (PRC) |
participant | DE | OPTI | OPTIMEDIS AG (PRC) |
participant | NL | NIVEL | STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG (REC) |
coordinator | ES | FAD | FUNDACION AVEDIS DONABEDIAN PARA LA MEJORA DE LA CALIDAD ASISTENCIAL (OTH) |
participant | ES | IR-HSCSP | FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU (REC) |
participant | EL | UOI | PANEPISTIMIO IOANNINON (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project EFOEUPATI this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | IE | IPPOSI | IRISH PLATFORM FOR PATIENTS' ORGANISATIONS SCIENCE AND INDUSTRY LIMITED BY GUARANTEE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
Within the project DigitalHealthEurope this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | RSCN | EIP ON AHA REFERENCE SITES COLLABORATIVE NETWORK (OTH) |
participant | IE | ECHA | ECHALLIANCE COMPANY LIMITED BY GUARANTEE (OTH) |
participant | BE | EAPM | EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL (REC) |
participant | ES | OE | OPEN EVIDENCE (PRC) |
participant | PT | SPMS | SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE (PUB) |
participant | NL | IFIC | STICHTING INTERNATIONAL FOUNDATIONFOR INTEGRATED CARE (REC) |
participant | SE | FUNKA | FUNKA NU AB (PRC) |
participant | FR | EUROREC | EUROPEAN INSTITUTE FOR HEALTH RECORDS (REC) |
participant | BE | ERRIN | EUROPEAN REGIONS RESEARCH AND INNOVATION NETWORK ASBL (OTH) |
participant | BE | LC | The Lisbon Council for Economic Competitiveness and Social Renewal asbl (OTH) |
participant | IT | INCE | INCE INIZIATIVA CENTRO EUROPEA - SEGRETARIATO ESECUTIVO (PUB) |
participant | BE | COCIR | COMITE EUROPEEN DE COORDINATION DES INDUSTRIES RADIOLOGIQUES ELECTROMEDICALES ET D INFORMATIQUE DE SANTE AISBL (OTH) |
participant | BE | EHTEL | EUROPEAN HEALTH TELEMATICS ASSOCIATION (REC) |
participant | BE | AGE | AGE PLATFORM EUROPE (OTH) |
coordinator | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | DE | FZJ | FORSCHUNGSZENTRUM JULICH GMBH (REC) |
Within the project EHDEN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CZ | Odysseus | ODYSSEUS DATA SERVICES SRO (PRC) |
participant | UK | ICHOM | INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT LTD (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | NL | THE HYVE | THE HYVE BV (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | PT | UAVR | UNIVERSIDADE DE AVEIRO (HES) |
participant | EE | TARTU | TARTU ULIKOOL (HES) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
coordinator | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project EU-PEARL this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Otsuka | OTSUKA NOVEL PRODUCTS GMBH (PRC) |
participant | US | CTF | CHILDREN'S TUMOR FOUNDATION (REC) |
participant | US | SpringWorks | SPRINGWORKS THERAPEUTICS INC (PRC) |
participant | DE | EUROSCAN | EUROSCAN INTERNATIONAL NETWORK EV (REC) |
participant | EE | DocuMental | DOCUMENTAL OU (PRC) |
participant | BE | i-HD | THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (REC) |
participant | IL | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | NL | EATRIS | EATRIS ERIC (REC) |
participant | UK | BERRY | BERRY CONSULTANTS LLP (PRC) |
participant | UK | AGN | ALLERGAN LIMITED (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | US | TB Alliance | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION (REC) |
participant | FR | Servier | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | PEI | BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL (PUB) |
participant | BE | JPNV | JANSSEN PHARMACEUTICA NV (PRC) |
coordinator | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | CUSTODIX | CUSTODIX NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IT | UNISR | UNIVERSITA VITA-SALUTE SAN RAFFAELE (HES) |
participant | UK | UMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | SE | Astrazeneca | ASTRAZENECA AB (PRC) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | IT | UMIL | UNIVERSITA DEGLI STUDI DI MILANO (HES) |
Within the project PERMIT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | UPDescartes | UNIVERSITE DE PARIS (HES) |
participant | NL | EATRIS | EATRIS ERIC (REC) |
coordinator | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | ES | PSSJD | PARC SANITARI SANT JOAN DE DEU (OTH) |
participant | ES | ISCIII | INSTITUTO DE SALUD CARLOS III (REC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | FR | UPDescartes | UNIVERSITE PARIS DESCARTES (HES) |
participant | LU | UdL | UNIVERSITE DU LUXEMBOURG (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | DE | DLR | DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV (REC) |
Within the project ImmUniverse this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
coordinator | IT | HUNIMED | HUMANITAS UNIVERSITY (HES) |
participant | BE | EFA | EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | FR | CHRU | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY (HES) |
participant | AT | AIT | AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH (REC) |
participant | DK | AUH | AARHUS UNIVERSITETSHOSPITAL (REC) |
participant | BE | VIB | VIB VZW (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | LU | UNILU | UNIVERSITE DU LUXEMBOURG (HES) |
participant | IT | SSSA | SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | DE | LMU | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | AT | JRF | JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
Within the project PharmaLedger this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
participant | UK | ONO | ONORACH LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | RO | RMS | ROMSOFT SRL (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project EATRIS-Plus this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
coordinator | NL | EATRIS | EATRIS ERIC (REC) |
participant | PT | INFARMED | INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP (PUB) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | ES | BIOCAT | BIOCAT LA FUNDACIO BIOREGIO DE CATALUNYA (OTH) |
participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | CZ | UP | UNIVERZITA PALACKEHO V OLOMOUCI (HES) |
participant | LV | RSU | RIGAS STRADINA UNIVERSITATE (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | BG | FCP-SU | SOFIA UNIVERSITY ST KLIMENT OHRIDSKI (HES) |
participant | SI | UL | UNIVERZA V LJUBLJANI (HES) |
participant | NO | UiO | UNIVERSITETET I OSLO (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | NL | SKU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | 03C CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FI | UHEL | HELSINGIN YLIOPISTO (HES) |